For a pdf version of this press release please click here.
AUSTIN, Texas, November 21, 2019 – Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management will participate at the Piper Jaffray 31st Annual Healthcare Conference, taking place December 3-5, 2019 in New York City.